Get the Stockscreener App
3.75
0.53%
-0.02
After Hours:
3.75
Accolade Inc stock is traded at $3.75, with a volume of 452.63K.
It is down -0.53% in the last 24 hours and up +17.55% over the past month.
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
See More
Previous Close:
$3.77
Open:
$3.8
24h Volume:
452.63K
Relative Volume:
0.36
Market Cap:
$308.05M
Revenue:
$414.29M
Net Income/Loss:
$-99.81M
P/E Ratio:
-1.9382
EPS:
-1.9348
Net Cash Flow:
$-28.65M
1W Performance:
+5.34%
1M Performance:
+17.55%
6M Performance:
-49.12%
1Y Performance:
-54.79%
1-Day Range:
$3.75
$3.85
1-Week Range:
$3.515
$3.925
52-Week Range:
$3.08
$15.36
Accolade Inc Stock (ACCD) Company Profile
Name
Accolade Inc
Sector
Industry
Phone
610-834-2989
Address
660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING
Compare ACCD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACCD
Accolade Inc
|
3.75 | 308.05M | 414.29M | -99.81M | -28.65M | -1.9348 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
Accolade Inc Stock (ACCD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Reiterated | Needham | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-17-24 | Resumed | DA Davidson | Neutral |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| May-24-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Mar-23-23 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-09-23 | Downgrade | Jefferies | Buy → Hold |
| Feb-02-23 | Initiated | Raymond James | Outperform |
| Sep-08-22 | Resumed | Piper Sandler | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| May-02-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Apr-29-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-29-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-29-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-29-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-29-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Underweight |
| Apr-07-22 | Initiated | Guggenheim | Neutral |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Sep-17-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| May-06-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-15-21 | Initiated | Needham | Buy |
| Mar-11-21 | Resumed | Goldman | Buy |
| Jan-15-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-08-20 | Initiated | Canaccord Genuity | Buy |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Jul-27-20 | Initiated | BofA Securities | Buy |
| Jul-27-20 | Initiated | Credit Suisse | Neutral |
| Jul-27-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | Morgan Stanley | Overweight |
| Jul-27-20 | Initiated | Piper Sandler | Overweight |
| Jul-27-20 | Initiated | Robert W. Baird | Outperform |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
View All
Accolade Inc Stock (ACCD) Latest News
Connor Clark & Lunn Investment Management Ltd. Acquires 215,958 Shares of Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Accolade, Inc. (NASDAQ:ACCD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Whetstone Capital Advisors LLC Takes Position in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Kerry company receives accolade at Asia Matters Awards - MSN
HP Inc triumphs at SBR Management Excellence Awards 2024 with two accolades - Singapore Business Review
Gear Inc. wins two accolades at SBR Management Excellence Awards 2024 - Singapore Business Review
Bahwan CyberTek COO clinches accolade at SBR Management Excellence Awards 2024 - Singapore Business Review
Accolade CFO Stephen Barnes sells $404 in stock By Investing.com - Investing.com Canada
Accolade CFO Stephen Barnes sells $404 in stock - Investing.com India
Accolade president Robert Cavanaugh sells $515 in shares By Investing.com - Investing.com South Africa
Acclade CEO Rajeev Singh sells $1,271 in stock - Investing.com India
Acclade CEO Rajeev Singh sells $1,271 in stock By Investing.com - Investing.com South Africa
Accolade president Robert Cavanaugh sells $515 in shares - Investing.com
Accolade, Inc. (NASDAQ:ACCD) Short Interest Down 5.3% in October - MarketBeat
Bellevue Group AG's Strategic Reduction in Accolade Inc Holdings - GuruFocus.com
Capital Securities Corporation wins top accolade for Best Securities Broker Brand for Media Volume - EIN News
Acclaimed president Robert Cavanaugh sells $778 in stock - Investing.com
Accolade CFO sells shares worth $811 - Investing.com
Acclolade CEO Rajeev Singh sells shares worth $2,430 - Investing.com
Accolade CFO sells shares worth $811 By Investing.com - Investing.com UK
Acclaimed president Robert Cavanaugh sells $778 in stock By Investing.com - Investing.com UK
Accolade To Present At Upcoming Investor Conferences - Barchart
Accolade (ACCD) Set to Present at Three Major Healthcare Investment Conferences | ACCD Stock News - StockTitan
Accolade To Present at Upcoming Investor Conferences - The Manila Times
ARK Investment Management LLC Trims Position in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Data Integration SpecialistExpats.cz - Expats.cz - Latest news for Prague and the Czech Republic
Knowledge Content AnalystExpats.cz - Expats.cz - Latest news for Prague and the Czech Republic
Help Desk Data AnalystExpats.cz - Expats.cz - Latest news for Prague and the Czech Republic
Horizon Aircraft receives Industry Excellence accolade at 2024 AIAC Aerospace Industry Awards - Vertical Magazine
Johnson Financial Group LLC Invests $1.64 Million in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Artistic Biomedical Limited Company Garners Two Accolades at the Asia Pacific Enterprise Awards 2024 Taiwan - Media OutReach
Accolade president sells shares worth $1,495 - Investing.com India
Accolade CEO Rajeev Singh sells shares worth $4,865 - Investing.com India
Accolade EVP Richard Eskew sells $1,058 in company stock - Investing.com
AcCOLade CFO Stephen Barnes sells $1,442 in stock By Investing.com - Investing.com UK
Accolade CEO Rajeev Singh sells shares worth $4,865 By Investing.com - Investing.com UK
Accolade EVP Richard Eskew sells $1,058 in company stock By Investing.com - Investing.com UK
Vanguard Group Inc's Strategic Acquisition of Accolade Inc Shares - GuruFocus.com
Accolade stock hits 52-week low at $3.12 amid market challenges - Investing.com Canada
Accolade stock hits 52-week low at $3.12 amid market challenges By Investing.com - Investing.com South Africa
Accolade Sports CollectionOfficial Trailer - GameRant
Accolade Sports Collection announced for Switch - Nintendo Everything
Analysts Set Accolade, Inc. (NASDAQ:ACCD) Price Target at $9.04 - MarketBeat
QUByte announces Accolade Sports Collection, scrolling brawler Blades & Battles, and a whole lot more - Games Asylum
Accolade And 2 Other Penny Stocks To Watch On US Exchanges - Simply Wall St
Short Interest in Accolade, Inc. (NASDAQ:ACCD) Rises By 5.6% - MarketBeat
Specialist, Knowledge ContentExpats.cz - Expats.cz - Latest news for Prague and the Czech Republic
Accolade shares soar on narrower quarterly loss, margin growth - MSN
Accolade Inc Stock (ACCD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Accolade Inc Stock (ACCD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SINGH RAJEEV | Chief Executive Officer |
Nov 19 '24 |
Sale |
3.35 |
380 |
1,271 |
796,109 |
| Cavanaugh Robert N | President |
Nov 18 '24 |
Option Exercise |
0.00 |
510 |
0 |
199,656 |
| Cavanaugh Robert N | President |
Nov 19 '24 |
Sale |
3.35 |
154 |
515 |
199,502 |
| Barnes Stephen H. | Chief Financial Officer |
Nov 18 '24 |
Option Exercise |
0.00 |
414 |
0 |
205,413 |
| Barnes Stephen H. | Chief Financial Officer |
Nov 19 '24 |
Sale |
3.35 |
121 |
405 |
205,292 |
| HILTON MICHAEL W | Director |
Nov 18 '24 |
Option Exercise |
0.00 |
332 |
0 |
150,430 |
0.88%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):